Evidence map›Paper›PMID 18083531›Full record

ReviewSeminars in immunology2008

Immune response to biologic scaffold materials.

Stephen F Badylak, Thomas W Gilbert

Abstract readReview
In one paragraph

Review in Seminars in immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 308 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
308citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

308 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Construction ofRegenerative biomaterials · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

248 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stephen F BadylakMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15219, United States. badylaks@upmc.edu
Thomas W Gilbert

Funding

Mechanisms of ECM Scaffold RemodelingR01EB000506 · NIBIB · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BADYLAK, STEPHEN F. · 2003 to 2006
$1.3M
Cellular Remodeling of ECM ScaffoldsR01AR054940 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BADYLAK, STEPHEN F. · 2007 to 2009
$935k
ORIGIN OF CELLS THAT REPOPULATE RESORBABLE ECM SCAFFOLDSR01GM060691 · NIGMS · PURDUE UNIVERSITY WEST LAFAYETTE · PI BADYLAK, STEPHEN F. · 2000 to 2001
$810k
NIAMS NIH HHS R01 AR054940NIBIB NIH HHS R01 EB000506NIGMS NIH HHS R01 GM060691
6 · The paper itself

Abstract

Biologic scaffold materials composed of mammalian extracellular matrix are commonly used in regenerative medicine and in surgical procedures for the reconstruction of numerous tissue and organs. These biologic materials are typically allogeneic or xenogeneic in origin and are derived from tissues such as small intestine, urinary bladder, dermis, and pericardium. The innate and acquired host immune response to these biologic materials and the effect of the immune response upon downstream remodeling events has been largely unexplored. Variables that affect the host response include manufacturing processes, the rate of scaffold degradation, and the presence of cross species antigens. This manuscript provides an overview of studies that have evaluated the immune response to biologic scaffold materials and variables that affect this response.

Indexed as

Biocompatible MaterialsImmunityTissue EngineeringTissue ScaffoldsAnimalsAntigens, HeterophileExtracellular Matrix ProteinsGuided Tissue RegenerationHumansLymphocyte ActivationMacrophage ActivationSwineTh1 CellsTh2 CellsTrisaccharidesalpha-galactosyl epitopeAntigens, HeterophileBiocompatible MaterialsExtracellular Matrix ProteinsTrisaccharides

Identifiers

PMID18083531
PMCPMC2605275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.